Smart and versatile drug delivery

Prolonged-release injection depot

FluidCrystal injection depot is designed to provide treatment efficacy over extended periods – with a single subcutaneous injection. This technology has the potential to reduce the burden of daily medication while increasing adherence to therapy.

Mode of drug delivery

The FluidCrystal injection depot comprises a lipid-based liquid with a dissolved active ingredient that is injected subcutaneously. Upon contact with fluids in the tissue, the lipid solution transforms into a liquid crystalline gel, which effectively encapsulates the active ingredient. The medicinal compound is slowly released as the liquid crystalline matrix gradually degrades in the tissue and the release can be controlled from several days to weeks or months depending on the composition.

Watch our short video below to understand how FluidCrystal technology works